Profile
Mr. Adam Townsend is a President, Chief Executive Officer & Director at Merida Biosciences, Inc. He is on the Board of Directors at Merida Biosciences, Inc. Mr. Townsend was previously employed as a Chief Operating Officer by Apellis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by Biogen, Inc., and a General Manager-UK, Ireland & Nordic Region by EUSA Pharma, Inc. He received his undergraduate degree from Royal Holloway University of London.
Adam Townsend active positions
| Companies | Position | Start |
|---|
Former positions of Adam Townsend
| Companies | Position | End |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Operating Officer | 2025-02-20 |
| BIOGEN INC. | Corporate Officer/Principal | 2018-09-30 |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Corporate Officer/Principal | 2010-02-28 |
Training of Adam Townsend
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Royal Holloway University of London
Royal Holloway University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Adam Townsend
















